Preparation and characterization of a new lipid nano-emulsion containing two cosurfactants, sodium palmitate for droplet size reduction and sucrose palmitate for stability enhancement

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 8, 2008, Pages 1097-1102

  Takegami, Shigehiko ^a   Kitamura, Keisuke ^a   Kawada, Hiroto ^a   Matsumoto, Yu ^a   Kitade, Tatsuya ^a   Ishida, Hiroharu ^a   Nagata, Chieyo ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Droplet size; Lipid nano emulsion; Sodium palmitate; Stability; Sucrose palmitate

Indexed keywords

FATTY ACID ESTER; LIPID EMULSION; PALMITATE SODIUM; PALMITIC ACID; PHOSPHATIDYLCHOLINE; SOYBEAN OIL; SUCROSE PALMITATE; SURFACTANT;

ARTICLE; ATOMIC FORCE MICROSCOPY; DRUG FORMULATION; DRUG STABILITY; DRUG STORAGE; LIGHT SCATTERING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE;

CHEMISTRY, PHARMACEUTICAL; CHEMISTRY, PHYSICAL; DRUG STABILITY; EMULSIONS; LIPIDS; NANOPARTICLES; NANOTECHNOLOGY; PALMITATES; PALMITIC ACID; PARTICLE SIZE; POLYSORBATES; SUCROSE; SURFACE-ACTIVE AGENTS; TECHNOLOGY, PHARMACEUTICAL;

EID: 48849102735     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.1097     Document Type: Article

References (27)

1. Matsumura Y., Maeda H., Cancer Res., 46, 6387-6392 (1986).
2. Maeda H., Adv. Drug Deliv. Rev., 6, 181-202 (1991).
3. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K., J. Controlled Release, 65, 271-284 (2000).
4. Maeda H., Sawa T., Konno T., J. Controlled Release, 74, 47-61 (2001).
5. Wisse E., J. Ultrastruct. Res., 31, 125-150 (1970).
6. Jain R. K., Cancer Metastasis Rev., 6, 559-593 (1987).
7. Jain R. K., Cancer Metastasis Rev., 9, 253-266 (1990).
8. Seki J., Sasaki H., Doi M., Yoshikawa H., Takahashi Y., Yamane S., Fukui H., Sonoke S., Yamamoto H., Hirose M., Ezure Y., Ando T., Ushimaru K., Sugiyama M., J. Controlled Release, 28, 352-353 (1994).
9. Miyamoto M., Hirano K., Ichikawa H., Fukumori Y., Akine Y., Tokuuye K., Chem. Pharm. Bull., 47, 203-208 (1999).
10. Dawes W. H., Groves M. J., Int. J. Pharm., 1, 141-150 (1978).
11. Borwankar R. P., Lobo L. A., Wasan D. T., Colloids Surf., 69, 135-146 (1992).
12. Yamaguchi T., Nishizaki K., Itai S., Hayashi H., Ohshima H., Pharm. Res., 12, 1273-1278 (1995).
13. Csóka G., Marton S., Zelko R., Otomo N., Antal I., Eur. J. Pharm. Biopharm., 65, 233-237 (2007).
14. Schäfer-Korting M., Mehnert W., "Lipospheres in Drug Targets and Delivery," Chap. 7, ed. by Nastruzzi C., CRC Press, Florida, 2005, pp. 127-142.
15. Rotenberg M., Rubin M., Bor A., Meyuhas D., Talmon Y., Lichtenberg D., Biochim. Biophys. Acta, 1086, 265-272 (1991).
16. Lundberg B., J. Pharm. Sci., 83, 72-75 (1994).
17. Badr M., Kodali D. R., Redgrave T. G., J. Colloid Interface Sci., 113, 414-420 (1986).
18. Handa T., Saito H., Miyajima K., Biochemistry, 29, 2884-2890 (1990).
19. Férézou J., Lai N.-T., Leray C., Hajri T., Frey A., Cabaret Y., Courtieu J., Lutton C., Bach A. C., Biochim. Biophys. Acta, 1213, 149-158 (1994).
20. Saito H., Nishiwaki K., Handa T., Ito S., Miyajima K., Langmuir, 11, 3742-3747 (1995).
21. Hosokawa T., Yamauchi M., Yamamoto Y., Iwata K., Nakamura A., Kato Y., Biol. Pharm. Bull., 26, 994-999 (2003).
22. Friebolin H., "Basic One- and Two-Dimensional NMR Spectroscopy," 3rd ed., Chap. 12, Wiley-VCH, Weinheim, 1998, pp. 331-341.
23. Ganem-Quintanar A., Quintanar-Guerrero D., Falson-Rieg F., Buri P., Int. J. Pharm., 173, 203-210 (1998).
24. Williams A. C., Barry B. W., Adv. Drug Deliv. Rev., 56, 603-618 (2004).
25. Li B., Li S., Tan Y., Stolz D. B., Watkins S. C., Block L. H., Huang L., J. Pharm. Sci., 89, 355-364 (2000).
26. Kamiya S., Nozawa Y., Miyagishima A., Kurita T., Sadzuka Y., Sonobe T., Chem. Pharm. Bull., 54, 181-184 (2006).
27. Blume G., Cevc G., J. Liposome Res,, 2, 355-368 (1992).